Full Text View
Tabular View
No Study Results Posted
Related Studies
Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)
This study is ongoing, but not recruiting participants.
Study NCT00135811   Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First Received: August 24, 2005   Last Updated: July 23, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Glomerulosclerosis, Focal
Additional conditions recognized in this trial
Glomerulosclerosis, Focal Segmental
More general conditions related to this trial
Glomerulonephritis
Kidney Diseases
Nephritis
Urologic Diseases
Interventions listed in this trial
Cyclosporin
MMF and Dexamethasone
Additional drug interventions recognized in this trial
Cyclosporine
Cyclosporins
Dexamethasone
Dexamethasone acetate
More general drug interventions related to this trial
Anti-Infective Agents
Anti-Inflammatory Agents
Antiemetics
Antifungal Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antirheumatic Agents
Autonomic Agents
Central Nervous System Agents
Dermatologic Agents
Enzyme Inhibitors
Gastrointestinal Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
The Cleveland Clinic


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services